Nephrocare Health Services acquires Philippine dialysis center for PhP 71.8 million
Nephrocare Health Services Limited’s Philippine subsidiary acquired dialysis assets in Davao City for PhP 71.8 million. The deal with Juan Nephro Dialysis Center is not a related-party transaction and involves no share issuance or special rights.

*this image is generated using AI for illustrative purposes only.
Nephrocare Health Services expanded its international footprint with the acquisition of dialysis center assets in the Philippines. The company’s overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services Philippines Inc., entered into an Asset Transfer Agreement dated August 12, 2026, to purchase identified assets from Juan Nephro Dialysis Center.
The transaction value stands at PhP 71,800,000 (Philippine Pesos Seventy-One Million Eight Hundred Thousand Pesos Only). The acquired assets relate to a dialysis center located in Davao City, Davao Del Sur, Philippines.
Transaction Details
The deal was structured as an asset purchase rather than a share acquisition. According to the disclosure made to stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, there are no special rights attached to the agreement, such as director appointments or subscription rights.
| Particulars | Details |
|---|---|
| Purchaser | Nephrocare Health Care Services Philippines Inc. |
| Seller | Juan Nephro Dialysis Center |
| Consideration | PhP 71,800,000 |
| Asset Location | Davao City, Philippines |
| Related Party? | No |
The seller is not related to the promoter group or group companies of Nephrocare Health Services. Consequently, the transaction does not fall within the scope of related-party transactions and was executed at arm’s length.
Regulatory Disclosure
Nephrocare Health Services Limited issued the disclosure pursuant to SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company confirmed that no shares were issued as part of this agreement, and no loan facilities were involved in the transaction structure.
Historical Stock Returns for Nephrocare Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.66% | -2.75% | +7.72% | +20.02% | +46.50% | +46.50% |
How does this acquisition impact Nephrocare's projected revenue growth and EBITDA margins from its international operations in the coming fiscal year?
What are the company's specific integration strategies for the Davao City center to ensure operational synergy with its existing Philippine network?
Does this asset purchase signal a broader strategic shift towards aggressive expansion in Southeast Asian markets, and if so, which other countries are on the radar?


































